EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Differences in the Fecal Metabolome of Autoimmune Pancreatitis Patients

Vladyslav Dovhalyuk iD, Fan Yang, Sara Nikolic, Miroslav Vujasinovic iD, J-Matthias Löhr iD, Daniel Globisch iD

United European Gastroenterology Journal · 2025

DOI: 10.1002/ueg2.70025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Vladyslav Dovhalyuk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry - BMC, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Feces, Autoimmune Pancreatitis, Metabolome, Gastrointestinal Microbiome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Commission, Vetenskapsrådet, Cancerfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic pancreatitis is a risk factor for pancreatic cancer. Autoimmune pancreatitis is a unique form of chronic pancreatitis that is primarily characterized by its immune mediate etiology, clinically resembling pancreatic cancer, yet uniquely responsive to steroid treatment.

Objective

Early and accurate diagnosis of autoimmune pancreatitis is vital for effective treatment and patient prognosis, for which new diagnostic tools are urgently required. Gut microbiota dysbiosis has been identified to correlate with the development of pancreatic diseases, which provides new opportunities for the discovery of disease biomarkers.

Methods

We utilized a mass spectrometric global metabolomics investigation of patient autoimmune pancreatitis and chronic pancreatitis fecal samples, investigating microbiome, dietary and human metabolism.

Results

We discovered a series of newly identified metabolic signatures between both patient groups including enterolactone, 4‐guanidinobutanoic acid, and methylthioadenosine sulfoxide. Additionally, the analysis revealed significant differences in several metabolic pathways such as fatty acids, alkaloids, amino acids and peptides.

Conclusion

Our observations provide novel insights into important metabolic human pathways and microbiome‐derived metabolites to distinguish autoimmune pancreatitis from chronic pancreatitis. These findings reveal systemic metabolic responses and the identified metabolites may be developed into potential biomarkers for future diagnosis to distinguish between autoimmune pancreatitis and chronic pancreatitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesAutoimmune PancreatitisMetabolomeGastrointestinal MicrobiomePancreatitis, ChronicHumansMaleFemaleMiddle AgedMetabolomicsBiomarkersAdultAgedDiagnosis, DifferentialMass SpectrometryDysbiosis

Stichwörter der Autor:innen

autoimmune pancreatitisbiomarkerschronic pancreatitisdysbiosisfecal metabolomicsgut microbiotamicrobiomepancreatic cancer

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Chemistry - BMC, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Department of Gastroenterology, Clinic of Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia.
  • Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden.
  • Department for Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden.

ORCID-Profile: Vladyslav Dovhalyuk, Miroslav Vujasinovic, J-Matthias Löhr, Daniel Globisch

Förderung

  • European Commission
  • Vetenskapsrådet
  • Cancerfonden

Zitieren

APA

Dovhalyuk, V., Yang, F., Nikolic, S., Vujasinovic, M., Löhr, J. M., & Globisch, D. (2025). Differences in the Fecal Metabolome of Autoimmune Pancreatitis Patients. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70025

Vancouver

Dovhalyuk V, Yang F, Nikolic S, Vujasinovic M, Löhr JM, Globisch D. Differences in the Fecal Metabolome of Autoimmune Pancreatitis Patients. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70025

BibTeX
@article{Dovhalyuk2025,
  author = {Dovhalyuk, Vladyslav and Yang, Fan and Nikolic, Sara and Vujasinovic, Miroslav and Löhr, J-Matthias and Globisch, Daniel},
  title = {Differences in the Fecal Metabolome of Autoimmune Pancreatitis Patients},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  doi = {10.1002/ueg2.70025}
}
Kostenlos starten →